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Abstract: Diabetes is the most important non-infectious disease affecting 5% of the general population. 
Different plant and mushroom extracts with hypoglycemic and antioxidant properties have been used 
traditionally as antidiabetic herbal medicines. The aim of this study was to study the in vivo effect of 
extracts obtained from the edible mushroom, Lactarius deterrimus (Ld), and chestnut, Castanea sativa 
(Cs), on the alleviation of liver damage in streptozotocin (STZ)-induced diabetic rats. The extracts were 
applied, either alone or in combination, for four weeks, starting from the last day of STZ administration. 
Diabetic rats treated with the extracts exhibited reduced hyperglycemia and lower hepatic oxidative stress. 
Extract treatment decreased the level of O-linkage of N-acetylglucosamine modified superoxide 
dismutase, catalase and NF-κB. Masson trichrome staining showed a decrease in collagen fiber deposition 
in the liver. Immunoblot analysis revealed the activation of the prosurvival Akt kinase after extract 
application. The obtained results revealed that the hyperglycemia-reducing and antioxidant effects of the 
Ld and Cs extracts suppressed cytotoxic signaling pathways, attenuating the negative effects of diabetes 
on the liver. The examined extracts are beneficial in the prevention of liver damage and could be 
considered for prediabetes and diabetes management after a definitive phytochemical description of 
extract constituents and subsequent evaluation in preclinical and clinical studies. 
 
Keywords: diabetes; Castanea sativa; Lactarius deterrimus; antioxidants; hepatoprotection 
 
Abbreviations and acronyms: advanced glycation end product (AGE); Castanea sativa (Cs); catalase 
(CAT); CCAAT/enhancer-binding protein β (C/EBPβ); diabetic animal group (DM); glutathione (GSH); 
glutathionylated proteins (GSSP); glycated Hb (GlyHb); hemoglobin (Hb); hexosamine biosynthetic 
pathway (HBP); intraperitoneal (i.p.); Lactarius deterrimus (Ld); non-diabetic animal group (NDM); 
nuclear factor kappa B (NFκB); O-linked N-acetyl glucosamine (O-GlcNAc); reactive oxygen species 
(ROS); oxidized glutathione/glutathione dimer (GSSG); protein kinase B (Akt); protein sulfhydryl groups 
(SH); quantitative real-time PCR (qRT-PCR); SDS-polyacrylamide gel electrophoresis (SDS-PAGE); 
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signal transducer and activator of transcription (STAT3); streptozotocin (STZ); superoxide dismutase 
(SOD); type 2 diabetes mellitus (T2D); uridine diphosphate N-acetylglucosamine (UDP-GlcNAc) 
 
INTRODUCTION 
There is extensive experimental evidence that persistent hyperglycemia promotes the production 
of reactive oxidative species (ROS) that participate in the pathogenesis of diabetes [1]. The 
imbalance between ROS production and removal due to a surge in reactive chemical species and 
impaired antioxidant defenses leads to increased cell death in different organs [2]. Diabetes-
induced oxidative stress in the liver plays an important role in the genesis of chronic liver disease 
in diabetes [1]. 
Insulin therapy is the only treatment for patients suffering from diabetes type 1 (T1D). 
There are six types of insulin available that are characterized by different acting times ranging 
from short-acting (such as regular insulin) to longer-acting (such as insulin glargine) insulin 
types [3]. Unfortunately, aside from its therapeutic value, insulin treatment can also have 
negative side effects. In addition, improper administration of insulin can result in transient and 
serious hypo- and hyperglycemia and wide glycemic excursions [3]. Reports have shown that 
natural antioxidants from higher plants and fungi can attenuate the complications of diabetes in 
experimental models and patients [4]. Natural plant extracts, either in the form of raw extracts or 
their chemical constituents, have been shown to be very efficient in the prevention of different 
pathologies linked to oxidative stress [5]. The flowers, fruits, leaves and skins of the sweet 
chestnut tree from the Fagaceae family, which grows in the Mediterranean region of Europe, 
have been widely used in folk medicine for treating various respiratory diseases [6,7]. Recent 
investigations have shown that the extract of the chestnut Castanea sativa possesses antiviral 
effects and the ability to lower oxidative stress and DNA damage [8,9]. Recent findings suggest 
that edible mushrooms are efficient antioxidants, possessing a radical scavenging activity whose 
antioxidant properties are effective in diabetes management [10]. Prevention of hepatic necrosis 
and the hepatoprotective effects related to increased activity of the antioxidant defense system by 
mushroom preparations have been described in animal models [11]. Lactarius deterrimus, an 
edible mushroom from the family Russulaceae, mainly grows in northern, northeastern and 
central Europe. Lactarius species represent a prospective source of natural immunostimulatory 
constituents with antitumor, antiviral and antimicrobial potential and activities [12,13]. 
We described the antioxidant properties of chestnut C. sativa (Cs) and mushroom L. 
deterrimus (Ld) extracts. Our findings revealed the in vitro effects of the extract on the 
prevention of lipid peroxidation, and on improved cell viability due to increased DNA protection 
from oxidative damage in STZ-induced rat pancreatic β-cell death [8]. We also showed that Cs 
and Ld extracts have the capacity to attenuate the complications observed in the pancreas, liver 
and kidney in STZ-induced diabetic rats [14,15]. Considering the positive properties of Ld and 
Cs extracts, we assumed that the administration of these extracts to diabetic rats would reduce 
hepatic oxidative stress and subsequent DNA damage that underlies liver tissue dysfunction in 
diabetes. In the present study we examined the beneficial in vivo effect of the application of Ld 
and Cs extracts on antioxidant protection and molecular mechanism of hepatoprotection in STZ-
induced diabetic rats. 
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MATERIALS AND METHODS 
Extraction procedures and characterization of the extracts 
Spiny burrs of the sweet chestnut (C. sativa Mill.) (Cs) were collected from the middle of 
September to the end of October in the Bihać region, western Bosnia and Herzegovina. The 
mushroom L. deterrimus (Ld) was collected in the summer in Istria, Croatia. Cs and Ld extract 
preparation, their total phenolic and flavonoid contents and qualitative and quantitative analyses 
were performed using the HPLC/DAD method as described [9,14,15]. 
Animals 
Experiments were performed on 2.5-month-old male albino Wistar rats weighing 220-250 g. All 
animal procedures complied with Directive 2010/63/EU on the protection of animals used for 
experimental and other scientific purposes and were approved by the Ethical Committee for the 
Use of Laboratory Animals of the Institute for Biological Research “Siniša Stanković”. The 
animals were housed in standard cages at 20ºC (±2º) with an artificial day/night rhythm and 
relative humidity of 60%±10%. 
Experimental protocol 
Diabetes was induced by intraperitoneal injection (i.p.) of 40 mg/kg STZ in 0.1 M sodium citrate 
buffer, pH 4.5 (MP Biomedicals, Solon, OH, USA), to male albino Wistar rats for five 
consecutive days. Blood glucose was measured 24 h after the last STZ injection (Accu-Chech 
Active, Roche Diagnostics Scientific Office, Cairo, Egypt) and rats were considered to have 
diabetes when the fasting blood glucose level exceeded 20 mmol/L. Rats were randomly divided 
into five groups as follows: (i) NDM – the non-diabetic group (n=7) which received a citrate 
buffer equivalent to the STZ injection for 5 consecutive days; (ii) DM – diabetic group (n=8) that 
was injected STZ for 5 consecutive days; (iii) DM+Cs – diabetic group (n=8) treated with the Cs 
extract daily for four weeks (60 mg/kg, i.p.), initiated on the last day of STZ administration; (iv) 
DM+Ld – diabetic group (n=8) treated with Ld daily for four weeks (60 mg/kg, i.p.), started on 
the last day of STZ administration; (v) DM+Cs/Ld – diabetic group (n=8) treated with the 
combination of Cs (60 mg/kg) and Ld (60 mg/kg) extracts daily for 4 weeks, started on the last 
day of STZ administration. Four weeks after diabetes induction the rats fasted overnight and 
blood serum was collected. Fasting blood glucose was measured using a commercial kit (Gluco-
quant Glucose/HK, Boehringer Mannheim, Germany). The animals were killed under light 
anesthesia (ketamine 80 mg/kg). For determination of glutathionylated proteins (GSSP), protein 
sulfhydryl groups (SH), antioxidant enzyme activities (MnSOD, CuZnSOD and CAT), 
immunoblot analysis and purification of O-GlcNAc-modified proteins, a 10% homogenate of 
fresh liver tissue was prepared in sucrose buffer (0.25 M sucrose, 1 mM EDTA, 0.05 M Tris-
HCl, pH 7.4), sonicated and centrifuged at 100,000 xg for 90 min. For GSH and GSSG 
determination, a 20% homogenate of fresh liver tissue was prepared in phosphate buffer (100 
mM NaH2PO4, 1 mM EDTA, pH 7.5). Aliquots of the supernatant were stored at -80°C. 
Determination of diabetes indicators in the serum 
The serum was obtained after blood clotting and centrifugation at 2,000 xg for 10 min. 
Hemoglobin (Hb) was determined according to Drabkin and Austin [16]. Glycated Hb (GlyHb) 
was determined by the colorimetric assay according to Parker et al. [17]. 
Determination of glutathionylated proteins in liver 
Acid-precipitated proteins in liver homogenates were thoroughly washed with the precipitating 
solution and the pellets were resuspended and brought to alkaline pH (pH 7.5-8) for 5-30 min. 
The reaction was stopped by the addition of trichloroacetic acid to a final 5% concentration. The 
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amount of released GSH was determined enzymatically in the supernatants after centrifugation 
[18]. 
Determination of protein sulfhydryl groups in liver 
Protein sulfhydryl groups (SH) were determined by Ellman’s method [19]. The amount of SH 
was calculated using the formula: 
mol SH/g protein=[(A sample/14150 × dilution factor]/g proteins. 
Determination of SOD and CAT activities in liver 
Total SOD (tot SOD) activity was measured in liver homogenates by the epinephrine method) 
[20] and expressed as U/g of wet mass. CAT activity was determined according to [21] by the 
rate of H2O2 decomposition and expressed as μmol H2O2/min/g of wet mass. 
Quantitative Real-time PCR (qRT-PCR) 
Total RNA was isolated from liver tissue using the RNeasy Mini Kit (Qiagen, Hilden, 
Düsseldorf, Germany) and reverse transcription was conducted using the QuantiNova Reverse 
Transcription Kit (Qiagen, Hilden, Germany). The amount of mRNA for cDNA synthesis was 
500 ng. Synthetized cDNA was diluted 1:9 in DNase-free water prior to RT-qPCR according to 
manufacturer’s recommendation. mRNA levels were quantitatively determined on an ABI Prism 
7000 Sequence Detection System (Applied Biosystems, Foster City, CA, USA) using SYBR-
green technology. The sequences of the utilized primers (Invitrogen, Waltham, MA USA) were: 
5΄-CAG ATC ATG CAG CTG CAC CA-3΄ and 5΄-TCA GTC CAG GCT GAA GAG CA-3΄ 
forward and reverse primers for the rat MnSOD gene, respectively; 5΄-GAC GAA GGC AAG 
CGG TGA AC-3΄ and 5΄-CGG CCA ATG ATG GAA TGC TC-3΄ forward and reverse primers, 
for the rat CuZnSOD gene, respectively; 5΄-GCG AAT GGA GAG GCA GTG TAC-3΄, and 5΄-
GAG TGA CGT TGT CTT CAT TAG CAC TG-3΄ forward and reverse primers for the rat CAT 
gene, respectively. To perform the real-time PCR reaction, 10 μL Maxima SYBR Green/ROX 
qPCR Master Mix (2x) were mixed with 400 ng of the cDNA template. The program of qRT-
PCR comprised an initial step at 50°C for 2 min, followed by an initial denaturation step at 95°C 
for 10 min, and a subsequent two-step PCR program at 95°C for 15 s, and 58°C for 60 s for 40 
cycles. PCR reactions were carried out in triplicate. The results are presented as 2-dCt, where 
dCt was the difference between Ct values of specific genes and endogenous control (β-actin). 
Detection of O-GlcNAc glycosylated proteins in the liver 
One hundred μg of liver homogenates in a total volume of 100 μL lysis buffer were pre-cleared 
with 50 μL of 50% (v/v) of non-conjugated agarose beads for elimination of nonspecific 
interactions of proteins with the agarose beads [22]. The supernatant was transferred to a new 
reaction tube and incubated with 50 μL of 50% (v/v) wheat germ agglutinin (WGA)-conjugated 
agarose beads (Sigma-Aldrich, St. Louis, MO, USA) overnight. The WGA-conjugated agarose 
beads were collected by centrifugation and washed three times. Equal aliquots of eluted proteins 
of all four experimental groups were separated by 12% SDS-PAGE. The protein gels were 
subjected to silver staining or analyzed by immunoblot analysis. 
SDS-PAGE and immunoblot analysis 
Twenty μg of liver homogenates or eluted O-GlcNAc-containing glycoproteins were separated 
by electrophoresis. Immunoblot analysis was performed using polyclonal antibodies to rat 
MnSOD, p65-NFκB, Akt, phosphorylated Akt, STAT3 and C/EBPβ (Santa Cruz Biotechnology, 
Santa Cruz, CA, USA) and CAT (Abcam, Cambridge, CB4 0FL, UK). Anti-β actin (Abcam, 
Cambridge, UK) and anti-lamin B (Santa Cruz Biotechnology, Santa Cruz, CA, USA) antibodies 
were used as loading controls. Immunoreactive bands were identified by an enhanced 
chemiluminescence (ECL) detection system (Santa Cruz Biotechnology, Santa Cruz, CA, USA) 
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according to the manufacturer’s instructions. The blots were normalized to the corresponding 
loading controls (actin for the cytosol fraction and lamin B for the nuclear fraction) and 
quantified by TotalLab [Phoretix] electrophoresis software [ver. 1.10]. 
Masson trichrome staining 
The livers from all experimental groups were removed, fixed in 10% buffered formalin and 
sectioned at 5 μm thickness. Sections of livers were stained with Masson trichrome stain for 
collagen fiber detection [23]. Tissue sections were observed under a light microscope (Leica 
DMLB; objective magnification was 40x). 
Statistical analysis 
Data were expressed as the means±SEM (standard error of mean) for 7-8 rats in each group. For 
intergroup comparison between two means, one-way analysis of variance (ANOVA) was used; 
in significant cases, Duncan’s multiple range test was applied. The difference was considered 
statistically significant at P<0.05. 
 
RESULTS 
Changes in body weight and biochemical parameters in STZ-induced diabetic rats treated 
with C. sativa and L. deterrimus extracts 
The changes in body weight from initial values and four weeks after treatments with Cs and Ld 
extracts are presented in Table 1. In the control group, a 19.5±0.2% increase in body weight was 
observed, which was in contrast to the diabetic group that displayed a 6.9±0.2% decrease in body 
weight (P<0.05). The decreases in body weights were lower in rats that were administered the 
extracts, with rats treated with Ld, Cs and Cs/Ld exhibiting decreases of 4.4±0.1%, 4.1±0.1% 
and 3.2±0.1%, respectively. 
The blood glucose concentration was significantly increased (P<0.05) in the diabetic 
group (30.1±1.12 mmol/l) (Supplementary Table S1). Treatment of diabetic animals with the Cs 
extract significantly reduced (P<0.05) the glucose concentration to 6.2±0.25 mmol/L, whereas 
treatment with the Ld extract reduced the glucose concentration to 22.7±0.94 mmol/L. Treating 
diabetic rats with the Cs/Ld mix also significantly reduced (P<0.05) blood glucose concentration 
(19.6±0.91 mmol/L). The concentration of GlyHb was 1.8-fold higher under diabetic conditions 
(Supplementary Table S1). Treating diabetic rats with the Cs extract reduced GlyHb to the 
control level. Treating diabetic rats with the Ld extract and with the Cs/Ld mix significantly 
reduced (P<0.05) the concentration of GlyHb to levels that were increased 1.4- and 1.3-fold, 
respectively, as compared to the control value (Supplementary Table S1). The serum levels of 
the markers of liver dysfunction, AST and ALT, increased 1.4- and 1.9-fold in the diabetic 
group, respectively, as compared to the intact control group (Supplementary Table S1). 
Treatment with the Cs extract slightly decreased the level of AST, while Ld and the combination 
of extracts further lowered the level of AST (P<0.05). Surprisingly, ALT remained unaffected by 
the Ld treatment; while Cs extract administration reduced ALT to the control level, and the 
Cs/Ld combination of extracts lowered the level of ALT to 1.5-fold above the control value 
(P<0.05) (Supplementary Table S1). 
Parameters of oxidative stress in the livers of Castanea sativa- and Lactarius deterrimus-
treated diabetic rats 
As can be seen in Fig. 1A, the level of GSSPs was 1.6-fold higher in the livers of diabetic rats as 
compared to the control (P<0.05). Treatment with the Cs extract completely restored the GSSPs, 
while the administration of Ld and the Cs/Ld mix lowered GSSPs 1.4- and 1.2-fold, respectively; 
which was above the intact control level. As can be seen in Fig. 1B, the SH content was 
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significantly lower (P<0.05) in the livers of diabetic rats. Treatments with all three extracts 
restored SH, with the best result observed with the Ld extract. 
Antioxidative protection in the liver of Castanea sativa- and Lactarius deterrimus-treated 
diabetic rats 
The results of examination of liver CuZnSOD, MnSOD and CAT enzyme activities are presented 
in Fig. 2A. The STZ treatment provoked a decline (P<0.05) of all examined antioxidant enzymes 
whereas treatment with Cs, Ld and the Cs/Ld mix recovered the activities of CuZnSOD, MnSOD 
and CAT (Fig. 2A). The effects of the treatments on antioxidant enzyme transcription levels in 
the liver are presented in Fig. 2B. In the diabetic state when compared to the control, the levels 
of expression of genes encoding for hepatic CuZnSOD, MnSOD and CAT decreased (P<0.05) 
1.9-, 1.3- and 2.4-fold, respectively. The transcriptional activities of CuZnSOD and MnSOD 
increased the most after administration of the Ld extract, whereas administration of the Cs/Ld 
mix caused CAT transcription to increase more than other treatments (Fig. 2B). 
One of the most frequent types of intracellular enzymatic glycosylation reactions is 
through the O-linkage of N-acetylglucosamine (O-GlcNAc), which impairs the activities of 
antioxidant enzymes. Immunoblot analysis with anti-CAT revealed the presence of O-GlcNAc-
modified CAT in the eluted fractions of diabetic rats after the Ld treatment (Fig. 2C). Treatments 
with Cs and the Cs/Ld mix decreased the level of glycosylated CAT (Fig. 2C). O-GlcNAc-
modified MnSOD was observed in the liver of diabetic rats. O-GlcNAc-modified MnSOD was 
lower after treatment with the Cs/Ld mix (1.4-fold lower compared to the diabetic group), 
whereas O-GlcNAc-modified MnSOD was completely absent after Cs or Ld administration (Fig. 
2C). The redox-sensitive nuclear transcription factor NF-κB was increased in the livers of 
diabetic rats and modified by O-GlcNAcylation (which was 5.2-fold higher than in the control) 
(Fig. 2C). In rats treated with either the Cs or Ld extracts, the fraction of NF-κB containing O-
GlcNAc was decreased 1.7-fold, remaining 3.4-fold higher than in the control. The lowest level 
of O-GlcNAc addition to NF-κB was observed after administration of the Cs/Ld mix (Fig. 2C). 
Akt, STAT3 and C/EBPβ protein distribution and expression in the liver of Castanea 
sativa- and Lactarius deterrimus-treated diabetic rats 
Immunoblot analysis (Fig. 3) revealed the presence of phosphoinositide-3-kinase (PI-3K)/protein 
kinase B (Akt), an important mediator of cellular prosurvival signals linked to proliferation and 
differentiation, and its active, phosphorylated form (pAkt). The ratio of pAkt to Akt decreased in 
the nuclear fraction of diabetic rats (P<0.05). The administration of Cs, Ld and the Cs/Ld mix 
increased the presence of pAkt in the nuclear fraction. The increased level of STAT3, associated 
with signal transduction in hepatic injury, was observed in the cytosol and its translocation to the 
nucleus under diabetic conditions (Fig. 3) (P<0.05) were decreased after administration of Cs, Ld 
and the Cs/Ld mix (Fig. 3) (P<0.05). STAT3 protein has an important function in interleukin 6 
(IL-6)-mediated transcription of the C/EBP-β gene, which is expressed during liver 
differentiation and which regulates the acute phase response in liver cells. As can be seen in Fig. 
3, the active 35 kD isoform of transcription factor C/EBP-β was increased in the liver of diabetic 
rats (P<0.05). Administration of Cs, Ld and the Cs/Ld mix of extracts reduced the level of 
C/EBP-β (Fig. 3) (P<0.05).  
Masson trichrome staining of the livers of non-diabetic and diabetic rats treated with 
Castanea sativa and Lactarius deterrimus extracts 
Masson trichrome staining of livers for collagen fiber deposition is presented in Fig. 4B. In the 
livers of control rats, minimal collagen deposition was observed around the central vein (Fig. 4, 
NDM). Hepatocytes formed long strips of tissue radiating from the periphery towards the central 
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vein, with no inflammatory infiltration and fatty degeneration. In the livers of untreated diabetic 
controls, lobular architecture was disordered and a prominent increase in collagen fiber 
deposition was detected around the central vein and between hepatocytes (Fig. 4, DM). Collagen 
fibers were decreased around the central vein and in the perisinusoidal region in the livers of Cs-, 
Ld- and Cs/Ld-treated diabetic rats. The hepatocytes remained polygonal and comparable to 
normal liver hepatocytes (Fig. 4, DM+Cs, DM+Ld and DM+Cs/Ld). 
DISCUSSION 
The present study revealed that treatments with Cs and Ld extracts, either individually or in 
combination (Cs/Ld), reduced the concentrations of blood glucose and glycated hemoglobin, O-
GlcNAc-modified antioxidant enzymes and NF-κB, and decreased proinflammatory signaling 
through restoration of the nuclear/cytosol redistribution of STAT3 and C/EBPβ, activated 
prosurvival Akt kinase and decreased collagen fiber deposition in the liver. 
Diabetes-related liver disorders include inflammation, fibrosis, cirrhosis, hepatocellular 
carcinoma and hepatitis [24]. The data presented herein describe a decrease in AST and ALT 
after administration of Cs and the Cs/Ld combination of extracts. A decrease in collagen fiber 
deposition that was observed in the liver in Cs-, Ld- and Cs/Ld-treated diabetic rats indicated that 
the fibrotic process, defined as excessive deposition of collagens, was reduced. Enhancement of 
biochemical markers as well as the decrease of the fibrotic process after extract treatment pointed 
to improved protection of liver cells/tissue to diabetes-induced damage. 
Hyperglycemia induces the overproduction of ROS that leads to oxidative damage of 
biomolecules such as DNA, proteins and lipids. The decrease in free SH and increased formation 
of GSSPs in the livers of diabetic rats revealed increased oxidative stress, which the antioxidant 
capacity of Cs and Ld was capable of significantly improving (i.e. the recovery of these 
parameters). Oxidative stress in diabetes lowers the antioxidant status and antioxidant defenses. 
The present study revealed that the activity of antioxidant enzymes, SOD and CAT, was 
decreased in diabetic animals, whereas treatment with Cs and Ld extracts recovered the activities 
of the antioxidant enzymes. The lower level of antioxidant enzyme activities in diabetic rats was 
accompanied by decreased expression of the corresponding genes. Treatments with extracts were 
followed by an increase in transcriptional activities of the Mn- and CuZnSOD genes, particularly 
after treatment with the Ld extract. The transcriptional activity of CAT was increased only in 
diabetic rats and after treatment with Cs/Ld; the profile of CAT transcriptional activity was not 
accompanied by a proportional increase in CAT enzyme activity. It has been reported that 
oxidative stress inactivates enzymes through protein glycation [6]. In diabetes, increased O-
GlcNAcylation is directly linked to hyperglycemia-induced glucose toxicity and diabetic 
complications, through the enzymatic addition of the N-acetyl glucosamine (GlcNAc) moiety to 
the hydroxyl groups of serine and/or threonine in nuclear and cytoplasmic proteins [24]. O-
GlcNAc is recognized as a stress-responsive modification which affects the stability, differential 
targeting and activity of proteins [26]. We observed that the decrease in antioxidant enzyme 
activities (MnSOD and CAT) in diabetic rats was accompanied by their increased O-GlcNAc 
modification. In addition, the increase in O-GlcNAc modification was also observed for redox-
sensitive nuclear transcription factor (NF-κB). 
Aside from the improvement of the antioxidant response in the livers of animals treated 
with Cs, Ld or Cs/Ld, the activation of the prosurvival Akt pathway is a very important aspect of 
the observed repair of liver damage in diabetic rats. Akt is a crucial regulator of cell proliferation 
and differentiation. Dietary polyphenols attenuate hyperglycemia, dyslipidemia and insulin 
resistance, alleviate oxidative stress and affect important cell signaling pathways involving NF-
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κB, activator protein-1 DNA binding, extracellular signal-regulated protein kinase (ERK), Akt, 
mitogen-activated protein kinases and nuclear factor erythroid 2 related factor 2 (Nrf2) [27]. The 
upregulation of this pathway in the liver of extract-treated diabetic rats was observed as 
phosphorylation of Akt. In addition to the slight disturbance in the nuclear/cytosol distribution of 
pAkt, the livers of diabetic rats displayed an altered nuclear/cytosol distribution of STAT3 and 
C/EBPβ which is characteristic of the proinflammatory state. The interplay of cytokine signaling 
pathways, which include tumor necrosis factor alpha (TNFα)/NF-κB, IL-6/STAT3, AP-1 and 
mitogen-activated protein kinase (MAPK)/extracellular signal-regulated protein kinase (ERK), 
as well as the prosurvival/antiapoptotic phosphatidylinositol 3-kinase (PI3K)/Akt pathway, 
assume important roles in cell/tissue regeneration [28]. In the abovementioned interplay, IL-6, 
which regulates STAT3 transcription by tethering STAT3 to liver-enriched activator protein 
(LAP)/C/EBPβ [29], assumes an important role. In addition, the constitutive activation of Akt 
and STAT3 are essential in cell survival [30]. Inflammatory signals contribute to the regulation 
of the acute phase response in the liver through the activities of transcription factors of the 
C/EBP family. Members of this family have also been implicated in liver regeneration where 
they regulate the process of hepatocyte proliferation and differentiation [29]. 
The anti-hyperglycemic potential of Cs described herein could be attributed to its high 
phenolic and flavonoid contents. Total phenols, polyphenols and many bioactive metabolites 
contained in mushroom extracts have been used in anti-hypoglycemic applications [10]. The 
important biological activities of mushrooms could also be attributed to cell-wall components 
such as β-glucans and polysaccharides, which possess important immunomodulatory activities 
and the ability to improve the systemic redox disturbance in diabetes through antioxidant and 
anti-inflammatory activities [10]. Synergistic effects of combinations of extracts in vivo have 
been observed to provide better protection than a single extract or compound [31]. However, the 
results in this study showed that Cs and Ld provided better results in some parameters that the 
Cs/Ld mix, however, the combination of Cs and Ld afforded the best effect in the prevention of 
body weight decrease, reduced GSH content, liver DNA damage and collagen fiber deposition. 
Although the combination of extract provided an additive beneficial effect, the lack of the 
synergistic outcome that was observed for some parameters in this study, could be the result of 
the reactivity of compounds present in the mixtures and their structural modifications that 
resulted in altered antioxidant activities [32-34]. 
The results obtained in this study provide important information about the beneficial 
effects of the examined extracts in the prevention of liver damage, revealing their considerable 
potential in prediabetes and diabetes management. However, the ultimate benefit of these 
extracts in a clinical context can only be properly evaluated in humans, in preclinical and clinical 
studies. Furthermore, the complex nature of natural plant extracts and variations in their 
constituents in different species, localities and preparations, render it essential that a consistent 
description of the product that can be further used in clinical trials is obtained. 
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Table 1. Net body weights of the experimental groups at the beginning and at the end of the 
experiment. 
 
Experimental groups 
Body weight (g) 
Beginning of the experiment End of the experiment 
NDM 230±9.2 274.6±9.8 
DM  236.7±9.4 223.3±8.7 
DM+Cs 223.3±8.9 213.3±8.5 
DM+Ld 240±7.2 230±7 
DM+Cs/Ld 225±7.8 216±8.2 
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Figure Legends 
 
Fig. 1. The effect of C. sativa and L. deterrimus extracts and their combination on the content of 
the level of glutathionylated proteins (GSSPs) (A) and the content of free sulfhydryl groups (SH) 
(B) in the liver of diabetic rats four weeks after administration of the last dose of STZ. NDM – 
control rats; DM – diabetic rats; DM+Cs – C. sativa extract treated diabetic rats; DM+Ld – L. 
deterrimus extract treated diabetic rats; DM+Cs/Ld – diabetic rats treated with the combination 
of Cs and Ld. The values are presented as the means±SEM for 7-8 rats in each group; values not 
sharing a common superscript letter differ significantly at P<0.05. 
 
Fig. 2. The effect of C. sativa and L. deterrimus extracts and their combination on the activities 
of antioxidant enzymes (A), the levels of antioxidant enzyme mRNAs (B), and on O-GlcNAc 
modified proteins (C) in the liver of diabetic rats four weeks after administration of the last dose 
of STZ. C – Immunoblot analysis with anti-CAT, anti-MnSOD and anti-NFκB antibodies of O-
GlcNAc modified proteins eluted from WGA-conjugated agarose beads. NDM – control rats 
(quantification of the immunoblots is presented in the tables; a representative blot of three 
independent experiments is shown); NDM– control rats; DM – diabetic rats; DM+Cs – C. sativa 
extract treated diabetic rats; DM+Ld – L. deterrimus extract treated diabetic rats; DM+Cs/Ld – 
diabetic rats treated with the combination of Cs and Ld. The values are presented as the 
means±SEM; values not sharing a common superscript letter differ significantly at P<0.05. 
 
Fig. 3. The effect of C. sativa and L. deterrimus and their combination on the distribution 
between cytosol and nuclear fraction of Akt, pAkt, STAT3 and C/EBPβ in the liver of diabetic 
rats four weeks after administration of the last dose of STZ. Immunoblot analysis was performed 
on the cytosol (c) and the nuclear protein fraction (n). NDM – control rats; DM – diabetic rats; 
DM+Cs – C. sativa extract treated diabetic rats; DM+Ld – L. deterrimus extract treated diabetic 
rats; DM+Cs/Ld – diabetic rats treated with the combination of Cs and Ld. The blots were 
normalized to the corresponding loading controls (actin for cytosol fraction and lamin B for 
nuclear fraction) and quantified by TotalLab [Phoretix] electrophoresis software [ver. 1.10]. A 
representative blot of three independent experiments is shown. The values are presented as the 
means±SEM; values not sharing a common superscript letter differ significantly at P<0.05. 
 
Fig. 4. The effects of individual application of C. sativa and L. deterrimus extracts and their 
combination on collagen fiber deposition by Masson trichrome staining in the liver of diabetic 
rats at four weeks after administration of the last dose of STZ. NDM – control rats; DM – 
diabetic rats; DM+Cs – C. sativa extract treated diabetic rats; DM+Ld – L. deterrimus extract 
treated diabetic rats; DM+Cs/Ld – diabetic rats treated with the combination of Cs and Ld. 
 
 
Supplementary Material 
 
The Supplementary Material is available at:  
http://serbiosoc.org.rs/NewUploads/Uploads/Mihailovic%20et%20al_5249_Supplementary%20
Material.pdf 
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